Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Our full-spectrum obesity management programs can be up and running in weeks
The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies
We worked exclusively with Reuters to better understand how first-time diagnosis patterns for people within 15 days of their first GLP-1 RA prescription and understand how this may have changed over time
Week 3-4 (or 5-8): If well-tolerated without adequate response, increase to 300mcg nightly
Wegovy 0.25mg FlexTouch Pen $364.99 BUY NOW Wegovy 0.5mg FlexTouch Pen $384.99 BUY NOW Wegovy 1.0mg FlexTouch Pen $404.99 BUY NOW Wegovy 1.7mg FlexTouch Pen $449.99 BUY NOW Wegovy 2.4mg FlexTouch Pen $469.99 BUY NOW Wegovy works by acting on receptors in the brain that control appetite, causing you to: Feel fuller after eating Experience less hunger between meals Have reduced food cravings Naturally eat less food, leading to weight loss Wegovy is approved for adults who have: Obesity: BMI of 30 kg/m or greater, OR Overweight with complications: BMI of 27-30 kg/m with weight-related health problems Heart disease risk reduction: Adults with existing heart disease (without diabetes) and BMI 27 kg/m Wegovy is a prescription medicine, your doctor will review your health status and eligibility as part of an assessment
US$ 29.37
US$ 28.51
US$ 24.28
US$ 25.70
US$ 25.46
